On July 30, 2008, ViroPharma Incorporated issued a press release announcing its financial results for its second quarter and six months ended June 30, 2008. A copy of the press release is set forth as Exhibit 99.1 attached hereto.
Item 9.01 Financial Statements and Exhibits.
The following exhibits are attached to this Form 8-K:
| (d) | Exhibit No. |
Description | ||
| 99.1 | Press release dated July 30, 2008 announcing financial results. | |||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VIROPHARMA INCORPORATED | ||||||
| Date: July 30, 2008 | By: | /s/ J. Peter Wolf | ||||
| J. Peter Wolf Vice President, General Counsel and Secretary | ||||||
Index of Exhibits
| Exhibit |
Description | |
| 99.1 | Press release dated July 30, 2008 announcing financial results. | |